Ionis Pharmaceuticals IONS Lease Payments
Lease Payments at other companies
Other financials
Where this comes from
Reported directly by Ionis Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:OperatingLeasePayments.
The official record: Ionis Pharmaceuticals’s 10-K, filed February 26, 2026, on SEC EDGAR. View the filing →
Ask your AI about Ionis Pharmaceuticals's lease payments.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Ionis Pharmaceuticals's lease payments?
- Ionis Pharmaceuticals (IONS) reported lease payments of $6.1M in Q4 2025.
- How has Ionis Pharmaceuticals's lease payments changed year-over-year?
- Ionis Pharmaceuticals's lease payments increased by 19.0% year-over-year, from $5.13M to $6.1M.
- What is the long-term trend for Ionis Pharmaceuticals's lease payments?
- Over 2 years (2023 to 2025), Ionis Pharmaceuticals's lease payments has grown at a 10.2% compound annual growth rate (CAGR), from $20.1M to $24.4M.
- What does lease payments mean?
- The total cash paid for rent and lease agreements during the period.
- How do you interpret lease payments?
- An increase indicates a growing physical footprint or rising rental costs, impacting operating cash flow.
- How does lease payments compare across companies?
- Standard disclosure under ASC 842; comparable across all companies with significant office or lab space leases.